| AstraZeneca AG - Trixeo Aerosphere 5/7.2/160 μg, Druckgasinhalation, Suspension | | 68388 | | 01 | | Trixeo Aerosphere 5/7.2/160 μg | | Druckgasinhalation, Suspension | | R03AL11 | | Formoterol, Glycopyrronium Bromide and Budesonide | | 24.11.2021 | | |
| | Composition | | budesonidum 160 µg, glycopyrronii bromidum 9 µg corresp. glycopyrronium 7.2 µg, formoteroli fumaras dihydricus 5 µg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, calcii chloridum dihydricum, trans-1,3,3,3-tetrafluoropropenum, ad suspensionem pro dosi. | | Packungsbestandteile | | | |
|
